All Categories
Sales increase from EUR 89.9 million to EUR 92.0 million EBITDA rises from EUR 10.3 million to EUR 10.4 million Forecast confirmed
AlzChem Group AG's (ISIN: DE000A0AHT46, ticker: SFP1) three majority shareholders, namely LIVIA Corporate Development SE, HDI Vier CE GmbH, and four two na GmbH, successfully sold in total 20,454,546 existing bearer shares with no par value in AlzChem Group AG, corresponding to approximately 20.1% of all outstanding bearer shares, in a private placement to institutional investors.
Today, AlzChem Group AG‘s three majority shareholders, namely LIVIA Corporate Development SE, HDI Vier CE GmbH, and four two na GmbH, published their decision to place existing shares in AlzChem Group AG, increasing the free-float in AlzChem’s ordinary bearer shares from approximately 1.2% to between approximately 21.3% and 28.0%, depending on the full placement size.
Disproportionately high earnings growth Dividend proposal of EUR 0.11 per share New Creamino® production plant scheduled to go on stream in mid-2019 Stable sales growth and above-average earnings growth expected
Our three majority shareholders today informed us about their intention to significantly increase AlzChem Group AG’s free-float by offering shares from their holdings in the near term.
Company aims to markedly expand its global market position with investments of EUR 7.2 million and a significant increase in capacities Broadening the product range will open new target markets and applications
Strategic step to further develop the fast-growing product EUR 50 million in investments planned to triple production capacities by mid-2019 Customer advantage through one-stop service
AlzChem Group AG (WKN: A0AHT4), a vertically integrated specialty chemicals supplier with a leading market position in select niche markets, held its Annual General Meeting in Munich today, May 23, 2018. 99.01 % of the share capital was represented at the Annual General Meeting. All items on the agenda were adopted by a large majority.